Designing Longevity
Skip to main content
Compounded GLP-1

Henry Meds

The full profile retains its earlier verification date. Check the dated program terms below before choosing.

Edited by Designing Longevity Editorial · earlier profile checked May 1, 2026

2.7

of 5 · earlier editorial rating
May 1, 2026

The editorial rating reflects checks from May 1, 2026. Program terms below have separate source dates. Neither is a medical or pharmacy inspection.

No financial relationship with Henry Meds. Editorial inclusion only.

Visit Henry Meds

Program costs and payment terms

Current program terms need a fresh check. Get a written price and billing quote directly before paying.

Membership
Current membership price needs a fresh check.
Insurance
Insurance terms need a fresh check; confirm directly before paying.

Designing Longevity is a founder-led editorial publication. Our content is not medically reviewed.

The full profile and rubric were last checked May 1, 2026. Current commercial terms above have their own check date; they do not refresh earlier ratings or clinical claims.

Earlier editorial take

Look elsewhere if

  • Users who want a clean per-fill sourcing chain

    Specific compounding-pharmacy partners are not publicly named at fill level, and there is no published lot-testing program. Eden's vertically-integrated model is meaningfully more transparent.

Our take

The full profile retains its earlier verification date. Check the dated program terms below before choosing.

Pros

  • Both oral and injectable options for and
  • No on Henry Meds or Adonis Health (verified vs Sept 2025 and March 2026 enforcement rounds)
  • Operating entity (Adonis Health, Inc.) is verifiable via federal court filings

Cons

  • F rating, NOT accredited; 192 complaints in three years with 25 unanswered
  • 4.5/5 average is undercut by a suspected-fraudulent-review notice on the profile page
  • Active Eli Lilly lawsuit (4:25-cv-03536) over marketing; personalization claim survived dismissal
  • Phone-only cancellation, no self-serve in-app flow; multiple complaints describe unanswered calls
  • certification not independently confirmable on a public registry

Pricing

Current pricing needs a fresh check.

Turnaround

Same-day Rx after async intake

States served

All 50

Earlier full review checked

May 1, 2026

Earlier rubric breakdown

How the earlier rating was scored

Licensure

20% weight
3.0/5

License and enforcement records checked at the profile verification date.

No on Henry Meds or Adonis Health, verified against the FDA warning-letter database at capture date and against the March 3, 2026 batch of 30 telehealth warning letters (Henry Meds was not on that list). Counterweight: an active Eli Lilly lawsuit (4:25-cv-03536, N.D. Cal., filed April 23, 2025) survived a partial motion-to-dismiss order on September 24, 2025, with the personalization-marketing claim allowed to proceed. The case is marketing/false-advertising, not product safety, but it is ongoing legal pressure rather than a closed chapter.

Evidence checked in the earlier review (4)

  • Adonis Health, Inc. d/b/a Henry Meds (operating entity)

    Business filing

    Confirmed via the docket caption in Eli Lilly and Company v. Adonis Health, Inc., 4:25-cv-03536, Northern District of California.

    Checked May 1, 2026 · source

  • No FDA warning letter on Henry Meds / Adonis Health

    Federal database

    Verified against the FDA warning-letter database. Specifically not named in either the September 2025 round of warning letters to telehealth companies or the March 3, 2026 batch of 30 letters. Several cohort competitors (Hims, MEDVi, Direct Meds) were in the September 2025 round; Henry Meds was not.

    Checked May 1, 2026 · source

  • Eli Lilly v. Adonis Health (Henry Meds) active lawsuit

    Civil litigation

    Eli Lilly filed in April 2025 alleging deceptive marketing of as 'personalized' and as equivalent to FDA-approved /. Sept 24, 2025 order from Judge Jon S. Tigar granted in part and denied in part Henry Meds's motion to dismiss; the personalization-marketing claim survived. Case remains active.

    Checked May 1, 2026 · source

  • Active state pharmacy / clinic licensure

    State licensure

    Henry Meds operates across all 50 states via licensed independent prescribers.

    Checked May 1, 2026

Accreditation

20% weight
1.5/5

Accreditation records checked at the profile verification date.

The weakest accreditation posture in our cohort. Henry Meds is NOT -accredited, with an F letter grade and 192 complaints filed over the last three years (25 of which received no response from the business). certification is unconfirmed on a public registry. There are no compensating accreditations to offset the BBB picture.

Evidence checked in the earlier review (2)

  • LegitScript Healthcare Merchant Certification

    Accreditation

    Not independently verifiable on a public registry. Henry Meds advertises on Google and Meta, which generally requires certification (Google's pharmacy advertising policy requires it for telehealth merchants), so it is a reasonable inference, but we cannot confirm against a public source the way we can confirm a profile.

    Checked May 1, 2026 · source

  • PCAB on partner compounding pharmacies

    Partner accreditation

    Specific compounding-pharmacy partners and their accreditation status are not publicly disclosed at the per-fill level.

    Checked May 1, 2026

Transparency

20% weight
2.5/5

Published testing, sourcing, and formulation information.

That structure is the most common complaint theme.

Evidence checked in the earlier review (1)

  • Compounded sourcing disclosure (compounded ≠ FDA-approved)

    Compliance disclosure

    Henry Meds publishes the standard -not-FDA-approved disclaimer.

    Checked May 1, 2026

Product quality

15% weight
3.0/5

Published testing, recall, and supply-chain information.

This earlier product-quality score has not been refreshed. The commercial update does not recheck manufacturing, sourcing or clinical care.

Evidence checked in the earlier review (4)

  • No FDA recalls on Henry Meds-distributed product

    Recall history

    Checked May 1, 2026 · source

  • Lawsuit scope: marketing, not safety

    Litigation scope

    The Eli Lilly case alleges deceptive marketing of 'personalized' , not unsafe or contaminated product. Important distinction when weighing product-quality risk.

    Checked May 1, 2026

  • Compounding partner identity at fill level

    Sourcing

    Specific or compounding partner per fill is not surfaced publicly. Less transparent than vertically-integrated competitors like Eden.

    Checked May 1, 2026

  • Third-party lot testing program

    Testing

    No publicly-detailed lot-by-lot testing program of the kind some competitors publish.

    Checked May 1, 2026

Pricing

15% weight
4.5/5

Value within the category, no surprise fees, refund policy.

Current pricing needs a fresh check.

Customer service

10% weight
2.0/5

Refund policy, support quality, complaint history.

The cohort's worst customer-service signal stack. shows F rating with 192 complaints in three years, 25 of which received no business response. Honest framing: do not trust the headline number alone.

Evidence checked in the earlier review (3)

  • BBB F rating with 192 complaints / 25 unanswered

    Complaint history

    F is the lowest grade. Twenty-five unanswered complaints is the responsiveness signal that drove the F.

    Checked May 1, 2026 · source

  • Trustpilot 4.5/5 across ~12,300 reviews, flagged for suspected fake reviews

    External review

    The 4.5-star headline is real, but itself displays a suspected-fraudulent-review notice on the page, which undercuts the credibility of the score. We are weighing the notice as more meaningful than the average.

    Checked May 1, 2026 · source

  • Async-only consultations, no labs before prescribing

    Care model

    Standard for the cohort, but worth noting alongside the broader concerns.

    Checked May 1, 2026

Public reviews

What we found across third-party review platforms. These are external sentiment signals, not our scoring inputs.

Trustpilot

4.5/5 across roughly 12,300 reviews on the surface, but the profile itself carries a suspected-fraudulent-review notice. We weight the notice heavily: the headline number does not mean what it appears to mean. Genuine positive themes still exist (convenience, fast shipping); negative themes match (cancellation friction, surprise charges).

Captured May 1, 2026Source

Better Business Bureau

F rating, NOT accredited. 192 complaints in three years; 25 received no business response. Complaint themes cluster on auto-renewal billing without delivery, a secondary $49/month subscription buried in terms of service, and cancellation resistance. The non-response rate is itself a signal.

Captured May 1, 2026Source

ConsumerAffairs

Recurring negative themes match : charged after cancellation, no medication delivered, no refund. Pattern matches enough that we treat it as a real signal across platforms rather than a single-platform anomaly.

Captured May 1, 2026Source

Regulatory & legal history

FDA enforcement actions, manufacturer lawsuits, recalls, and other notable events on the public record.

  1. Lawsuit FiledApril 23, 2025

    Eli Lilly and Company filed Eli Lilly v. Adonis Health, Inc. d/b/a Henry Meds (Case 4:25-cv-03536) in the U.S. District Court for the Northern District of California, alleging deceptive marketing of oral as 'personalized' and as equivalent to FDA-approved and . Lanham Act and California consumer-protection claims.

    Source
  2. Lawsuit FiledSeptember 24, 2025

    Judge Jon S. Tigar issued an order granting in part and denying in part Henry Meds's motion to dismiss. Personalization-marketing claim was allowed to proceed; a separate 'safe and effective' marketing claim was dismissed. Eli Lilly was given until October 15, 2025 to file an amended complaint. Case remains active as of capture date.

    Source

What to expect

  1. 1

    Async intake form

    10-15 min

    Online intake covering current weight, BMI, medical history, and weight-loss goals. No labs ordered before prescribing (cohort-typical for telehealth).

  2. 2

    Clinician review

    Same day

    Licensed clinician reviews the intake and issues a prescription if appropriate. Same-day is the typical outcome.

  3. 3

    Compounding pharmacy fulfillment

    3-7 days

    Approved routes to a partner compounding pharmacy. Cold-chain shipping for injectables; tablets ship standard. Specific partner per fill is not publicly disclosed.

Accreditations

State pharmacy/clinic license

Verified · May 1, 2026

LegitScript Certified

Unverified · May 1, 2026 · source

Frequently asked

What does Henry Meds charge for membership?

Current membership price needs a fresh check.

Does Henry Meds accept insurance?

Insurance terms need a fresh check; confirm directly before paying.

What is the Eli Lilly lawsuit against Henry Meds?

Eli Lilly and Company v. Adonis Health, Inc. d/b/a Henry Meds (Case 4:25-cv-03536) was filed April 23, 2025 in the U.S. District Court for the Northern District of California. Lilly alleges Henry Meds deceptively markets as 'personalized' and as equivalent to Lilly's FDA-approved and . On September 24, 2025, Judge Jon S. Tigar granted in part and denied in part Henry Meds's motion to dismiss; the personalization-marketing claim survived. The case is about marketing language, not product safety, but it is active litigation rather than a closed chapter.

Update history

Every meaningful change to this profile, with a date stamp. We don't silently re-score.

  1. May 1, 2026

    Initial published profile. Sources HEAD-checked at publish time. Score (2.7) reflects the cohort-cheapest pricing weighted against the cohort-worst trust posture: F with 25 unanswered complaints, suspected-fraudulent-review notice, and active Eli Lilly v. Adonis Health (4:25-cv-03536) over - marketing. Honest framing: list Henry Meds because the price gap is real, but route most readers to TrimRx or Eden for trust posture.

Edited by Designing Longevity Editorial. Earlier profile checked May 1, 2026.

Spot something out of date or wrong? Let us know and we'll re-check.

Back to all providers